表纸
市场调查报告书

寡核苷酸合成的全球市场 - 成长率,趋势及预测(2019年~2024年)

Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品编码 649746
出版日期 内容资讯 英文 115 Pages
商品交期: 2-3个工作天内
价格
Back to Top
寡核苷酸合成的全球市场 - 成长率,趋势及预测(2019年~2024年) Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日内容资讯: 英文 115 Pages
简介

全球寡核苷酸合成市场,由于政府的投资及制药公司和生物科技企业的研究开发费增加,以及分子诊断及临床应用的合成寡核苷酸的有效利用等要素而成长。

本报告提供全球寡核苷酸合成市场调查,整体市场趋势,各产品、地区的详细趋势,市场成长的影响要素分析,竞争情形,主要企业简介等资讯汇整。

目录

第1章 简介

  • 调查的成果
  • 调查的前提条件
  • 调查范围

第2章 调查方法

第3章 摘要整理

第4章 市场动态

  • 市场概况
  • 市场成长要素
    • 政府投资及制药、生物科技企业的研究开发费的增加
    • 分子诊断及临床应用的合成寡核苷酸的有效利用
  • 市场阻碍因素
    • 合成寡核苷酸的价格下降
  • 波特的五力分析
    • 新加入厂商的威胁
    • 买主/买方议价能力
    • 供应商谈判力
    • 替代产品的威胁
    • 产业内的竞争激烈度

第5章 市场区隔

  • 各产品类型
    • 合成寡核苷酸生成决裂
    • 各试剂
    • 各设备
  • 各应用领域
    • 各研究
    • 各诊断
    • 各治疗
  • 各终端用户
    • 学术研究机关
    • 制药、生物科技企业
    • 诊断研究所
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第6章 竞争情形

  • 企业简介
    • Agilent Technologies
    • Thermo Fisher Scientific
    • Merck KGaA
    • Bio-Synthesis Inc.
    • Eurofins Genomics
    • Eurogentec
    • GE Healthcare
    • GenScript
    • Integrated DNA Technologies Inc.
    • LGC Biosearch Technologies

第7章 市场机会及未来趋势

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 60475

Market Overview

The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.

The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods and are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.

Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.

In addition, there are also other major factors influencing the market for oligonucleotide synthesis. This includes the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investment by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

Scope of the Report

As per the scope of the report, oligonucleotides are short fragments of nucleic acids that are synthesized using genetic engineering and enzyme chemistry. These are mostly used in laboratories in applications, such as therapeutic, diagnostics, as well as academic and industrial. These are used from initial research and screening through to target validation and drug production. Nowadays, subsequent improvements in oligonucleotide synthesis, amplification, and automation have completely revolutionized biological research. It is also possible to do the customizations and get the required sequence online easily and at the required time. These services vary greatly by the cost of per base pair, error rates, lengths, throughput, etc.

Key Market Trends

Academic Research Institutes are the Largest Segment Under End User that is Expected to Grow in the Forecast Period

The government and private entities are found investing in the development of academic and research infrastructure in the emerging economies. This factor is positively boosting the oligonucleotide adoption in academic research institutes. There is an increase in the genomic research projects conducted by academic research institutes that have enabled the segment to account for the dominant share in the market.

North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

North America dominates the market due to the presence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share.

Competitive Landscape

The companies are seen adopting various strategies adopted by the competitors that include the acquisition of players in emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolio that helps to drive the overall market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
    • 4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
  • 4.3 Market Restraints
    • 4.3.1 Price Erosion of Synthesized Oligonucleotides
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 By Synthesized Oligonucleotide Product
      • 5.1.1.1 Primers
      • 5.1.1.2 Probes
      • 5.1.1.3 Large-scale Synthesis Oligonucleotides
      • 5.1.1.4 Intermediate-scale Synthesis Oligonucleotides
      • 5.1.1.5 Other Synthesized Oligonucleotide Product Types
    • 5.1.2 By Reagents
    • 5.1.3 By Equipment
  • 5.2 By Application
    • 5.2.1 By Research
      • 5.2.1.1 PCR
      • 5.2.1.1.1 QPCR
      • 5.2.1.1.2 Sequencing
      • 5.2.1.1.3 Gene Synthesis
      • 5.2.1.1.4 Other Research Application
    • 5.2.2 By Diagnostics
    • 5.2.3 By Therapeutics
      • 5.2.3.1 RNAi
      • 5.2.3.2 Nucleic Acid Aptamers
      • 5.2.3.3 DNA/Antisense Oligonucleotides
      • 5.2.3.4 Other Therapeutics
  • 5.3 By End User
    • 5.3.1 Academic Research Institutes
    • 5.3.2 Pharmaceutical and Biotechnology Companies
    • 5.3.3 Diagnostic Laboratories
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Bio-Synthesis Inc.
    • 6.1.5 Eurofins Genomics
    • 6.1.6 Eurogentec
    • 6.1.7 GE Healthcare
    • 6.1.8 GenScript
    • 6.1.9 Integrated DNA Technologies Inc.
    • 6.1.10 LGC Biosearch Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top